ATC Group: A06AC01 Ispaghula (psylla seeds)

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A06AC01 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Laxatives
3
Laxatives
4
Bulk producers
5
A06AC01
Ispaghula (psylla seeds)

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
7 g

Active ingredients in A06AC01

Active Ingredient
Description

Ispaghula is particularly rich in alimentary fibres and mucilages. Ispaghula is capable of absorbing up to 40 times its own weight in water. Gut motility and transit rate can be modified by ispaghula through mechanical stimulation of the gut wall as a result of the increase in intestinal bulk by water and the decrease in viscosity of the luminal contents.

Medicines in this ATC group

Drug
Countries

Ecuador

New Zealand

Ireland South Africa Turkey United Kingdom

United Kingdom

New Zealand

Brazil Hong Kong Netherlands New Zealand

Ecuador

Estonia Turkey

Ecuador

Hong Kong

Brazil Ecuador Hong Kong

Netherlands

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
UK